Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_assertion type Assertion NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_head.
- NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_assertion description "[In agreement with these data, pharmacologic inhibition of PDE4 in a xenograft model of human lymphoma unleashed cAMP effects, inhibited AKT, and restored GC sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_provenance.
- NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_assertion evidence source_evidence_literature NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_provenance.
- NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_assertion SIO_000772 21742807 NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_provenance.
- NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_assertion wasDerivedFrom befree-20150227 NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_provenance.
- NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_assertion wasGeneratedBy ECO_0000203 NP613016.RAqOmazH5c3bBqatDdRRDl0Qp5WBcHVae10s-49CvXC6U130_provenance.